REAL WORLD EVIDENCE OF THE RISK OF A SECOND CANCER AMONG TESTICULAR CANCER PATIENTS AFTER CISPLATIN-BASED TREATMENT

被引：0
|
作者：
Luciano, S. [1 ]
Fazio-Eynullayeva, E. [2 ]
Kuranz, S. [1 ]
Stetson, B. [1 ]
机构：
[1] TriNetX Inc, Cambridge, MA USA
[2] TriNetX Inc, Revere, MA USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN183
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] RETINAL TOXICITY AFTER CISPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER
    Gild, Philipp
    Vetterlein, Malte W.
    Dieckmann, Klaus-Peter
    Matthies, Cord
    Wagner, Walter
    Ludwig, Tim A.
    Meyer, Christian P.
    Soave, Armin
    Dulz, Simon
    Asselborn, Niels H.
    Oechsle, Karin
    Bokemeyer, Carsten
    Becker, Andreas
    Fisch, Margit
    Hartmann, Michael
    Chun, Felix K. H.
    Kluth, Luis A.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1085 - E1085
  • [2] Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
    Garcia, Sara L.
    Lauritsen, Jakob
    Christiansen, Bernadette K.
    Hansen, Ida F.
    Bandak, Mikkel
    Dalgaard, Marlene D.
    Daugaard, Gedske
    Gupta, Ramneek
    CANCERS, 2023, 15 (15)
  • [3] Life expectancy 20 years after cisplatin-based treatment for testicular cancer (TC).
    Lubberts, Sjoukje
    Kruyt, Lara M.
    Steggink, Lars Christiaan
    Steursma, Gerrie
    Nuver, Janine
    Oosting, Sjoukje
    van Ginkel, Robert J.
    de Jong, Igle J.
    Eulenburg, Christine
    Lefrandt, Joop D.
    Meijer, Coby
    Sluiter, Wim J.
    Gietema, Jourik A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] High risk vascular fingerprint in patients treated with cisplatin-based chemotherapy for testicular cancer
    Lubberts, Sjoukje
    Boer, Hink
    Altena, Renske
    Meijer, Coby
    van Roon, Arie M.
    Zwart, Nynke
    Oosting, Sjoukje
    Kamphuisen, Pieter W.
    Nuver, Janine
    Smit, Andries J.
    Mulder, Andre B.
    Lefrandt, Joop D.
    Gietema, Jourik A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] ACUTE CEREBROVASCULAR EVENT AFTER CISPLATIN-BASED CHEMOTHERAPY FOR TESTICULAR CANCER
    GERL, A
    CLEMM, C
    WILMANNS, W
    LANCET, 1991, 338 (8763): : 385 - 386
  • [6] Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer Patients
    Garcia, Sara L.
    Lauritsen, Jakob
    Zhang, Zeyu
    Bandak, Mikkel
    Dalgaard, Marlene D.
    Nielsen, Rikke L.
    Daugaard, Gedske
    Gupta, Ramneek
    JNCI CANCER SPECTRUM, 2020, 4 (03)
  • [7] Prediction of nephrotoxicity associated with cisplatin-based chemotherapy in testicular cancer patients
    Garcia, S.
    Lauritsen, J.
    Zhang, Z.
    Dalgaard, M. D.
    Nielsen, R. L.
    Daugaard, G.
    Gupta, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1686 - 1686
  • [8] Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy
    Navari, Rudolph M.
    Nelson, Winnie W.
    Shoaib, Sofia
    Singh, Risho
    Zhang, Weiping
    Bailey, William L.
    ADVANCES IN THERAPY, 2023, 40 (07) : 3217 - 3226
  • [9] Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy
    Rudolph M. Navari
    Winnie W. Nelson
    Sofia Shoaib
    Risho Singh
    Weiping Zhang
    William L. Bailey
    Advances in Therapy, 2023, 40 : 3217 - 3226
  • [10] Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer
    Altena, R.
    Hummel, Y. M.
    Nuver, J.
    Smit, A. J.
    Lefrandt, J. D.
    de Boer, R. A.
    Voors, A. A.
    van den Berg, M. P.
    de Vries, E. G. E.
    Boezen, H. M.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2011, 22 (10) : 2286 - 2293
12345